Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NovoCure (NVCR) Q3 2026 Earnings
NVCR
23
Jul
Confirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.62
-0.46
-0.29
-0.13
Details
Expected EPS
-0.331533
Actual EPS
-0.13
Surprise EPS
0.2
Surprise Percent
+60.79%
Description
NovoCure (NVCR) has reported earnings of -0.13 per share for Q3 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login